BlackRock Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock Group’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$63K	Hold	11,200	–	–	﹤0.01%	2891
2016 Q3	$62K	Hold	11,200	–	–	﹤0.01%	2889
2016 Q2	$79K	Hold	11,200	–	–	﹤0.01%	2841
2016 Q1	$74K	Hold	11,200	–	–	﹤0.01%	2837
2015 Q4	$115K	Hold	11,200	–	–	﹤0.01%	2656
2015 Q3	$132K	Buy	+11,200	New	+$124K	﹤0.01%	2634

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Group's JNP Position: Q4 2016 in Review

BlackRock Group held its Juniper Pharmaceuticals, Inc. Common Stock (JNP) position steady in Q4 2016 at 11,200 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

BlackRock Group first reported a position in JNP in Q3 2015 and has held it in 6 quarters since. The position peaked at $132K in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

BlackRock Group held 11,200 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $63K as of Q4 2016.
BlackRock Group left its Juniper Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2016.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2891 holding.
BlackRock Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
BlackRock Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $132K in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.